Home › Obesity › Virginia

Pag-aaral pangklinika para sa Obesity sa Virginia

44 pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa mga site sa Virginia.

Mga Lungsod sa Virginia

Opisyal na teksto ng pag-aaral (English)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Washington Center For Weight Management And Research /ID# 282047, Arlington
Sovah Health - Danville /ID# 282876, Danville
Health Research Of Hampton Roads /ID# 282014, Newport News
at 1 pa

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Washington Cntr Weight Mgmt, Arlington
Health Res of Hampton Roads, Newport News
National Clin Res Inc., Richmond

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

National Clin Res Inc., Richmond
Gastroent Consult of SW VA, Roanoke

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

York Clinical Research, LLC, Norfolk

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Manassas

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07776509

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Washington Cntr Weight Mgmt, Arlington
Health Res of Hampton Roads, Newport News
Selma Medical Associates, Winchester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07339423

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

VCU Health - Center for Endocrinology Diabetes and Metabolism, Richmond

Nagre-recruitPhase 3

Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Consultants of Southwest Virginia, Roanoke

Nagre-recruitPhase 3

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Sovah Clinical Research-River District, Danville

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07589608

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Carient Heart & Vascular - Manassas, Manassas
Carient Heart and Vascular LLC-Reston, Reston

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07783802

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

Charlottesville Medical Research, Charlottesville
Gershon Pain Specialists, Virginia Beach

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07153471

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Manassas
Research Site, Norfolk

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Charlottesville Medical Research, Charlottesville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

AMR Clinical, Norfolk

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Inova Cardiology - Fairfax, Fairfax
Virginia Heart, Falls Church

Nagre-recruitPhase 3

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Hampton

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Hampton

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Conquest Research, LLC, Arlington
Virginia Heart, Falls Church
Carient Heart and Vascular, Manassas
at 2 pa

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Manassas Clinical Research Center, Manassas
Centricity Research Suffolk Primary Care, Suffolk

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Burke
ACCOMPLISH-2 Research Site, Manassas
ACCOMPLISH-2 Research Site, Suffolk

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Selma Medical Associates, Winchester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07770841

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
Clinical Research Partners, LLC, Richmond

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Sovah Clinical Research-River District, Danville

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06143956

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

National Clin Res Inc., Richmond

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07533175

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Health Res of Hampton Roads, Newport News
National Clin Res Inc., Richmond
Selma Medical Associates, Winchester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07745504

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Danville

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Manassas Clinical Research Center Inc, Manassas

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Manassas
Kailera Clinical Site, Richmond

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Washington Center for Weight Management and Research, Inc, Arlington
Health Research of Hampton Roads, Newport News
Selma Medical Associates, Winchester

Nagre-recruitPhase 3

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07684235

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Kailera Clinical Site, Manassas
Kailera Clinical Site, Richmond

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07284979

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Arlington

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

University Of Virginia Hospital, Charlottesville
Carient Heart and Vascular, Manassas
TPMG Clinical Research, Newport News
at 4 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Health Res of Hampton Roads, Newport News

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Charlottesville Medical Research, Charlottesville

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07477704

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Charlottesville Med Research, Charlottesville
Health Res of Hampton Roads, Newport News

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07481630

Brief Inhibitory Training for Eating - Intervention

George Mason University, Fairfax

Nagre-recruit

Edad 14 hanggang 17 · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT07592728

Advancing Water Security: A Community Participatory School-Based Hydration Intervention

Children's Hospital of Richmond at VCU Healthy Lifestyles Center, Henrico

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 4 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06714929

Redefining BMI: The Body, Mind, and Inflammation Trial

Virginia Commonwealth Universtity, Richmond

Nagre-recruit

Edad 18 hanggang 25 · Kababaihan · Na-update May 6, 2026 · NCT06532747

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Vanda Investigational Site, Burke

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT07446439

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

University of Virginia Medical Center, Charlottesville

Nagre-recruitPhase 2

Edad 12 hanggang 21 · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06903923

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.